Clinical Trial Update: Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men [Phase 3]

View source ↗

Summary

Phase 3 extension trial evaluating ambulatory blood pressure monitoring for oral testosterone undecanoate in hypogonadal men has completed and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Oral testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: Marius Pharmaceuticals | Conditions: Hypogonadism, Male | Phase 3 | Status: COMPLETED | Results posted: 2024-06-28